EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic yield and clinical impact of chromosomal microarray analysis in autism spectrum disorder

Francesca Cucinotta iD, Carla Lintas iD, Pasquale Tomaiuolo iD, Marco Baccarin, Chiara Picinelli, Paola Castronovo, Roberto Sacco, Ignazio Stefano Piras iD, Laura Turriziani, Arianna Ricciardello, Maria Luisa Scattoni iD, Antonio M Persico iD

Molecular Genetics & Genomic Medicine · 2023-08 · 11 (8)

DOI: 10.1002/mgg3.2182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 25.04.2023. Verfasst von Francesca Cucinotta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Interdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Autistic Disorder. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autism spectrum disorder (ASD) is characterized by high heritability estimates and recurrence rates; its genetic underpinnings are very heterogeneous and include variable combinations of common and rare variants. Array‐comparative genomic hybridization (aCGH) offers significant sensitivity for the identification of copy number variants (CNVs), which can act as susceptibility or causal factors for ASD.

Methods

The aim of this study was to evaluate both diagnostic yield and clinical impact of aCGH in 329 ASD patients of Italian descent.

Results

Pathogenic/likely pathogenic CNVs were identified in 50/329 (15.2%) patients, whereas 89/329 (27.1%) carry variants of uncertain significance. The 10 most enriched gene sets identified by Gene Ontology Enrichment Analysis are primarily involved in neuronal function and synaptic connectivity. In 13/50 (26.0%) patients with pathogenic/likely pathogenic CNVs, the outcome of array‐CGH led to the request of 25 additional medical exams which would not have otherwise been prescribed, mainly including brain MRI, EEG, EKG, and/or cardiac ultrasound. A positive outcome was obtained in 12/25 (48.0%) of these additional tests.

Conclusions

This study confirms the satisfactory diagnostic yield of aCGH, underscoring its potential for better, more in‐depth care of children with autism when genetic results are analyzed also with a focus on patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderAutistic DisorderChildHumansComparative Genomic HybridizationMicroarray AnalysisDNA Copy Number Variations

Stichwörter der Autor:innen

15q11.2-q13.1 duplication syndrome16p11.2 microdeletion syndromearray comparative genomic hybridizationautism spectrum disordercopy number variantsgene set enrichment analysisgenotype-phenotype correlationneurodevelopmental disorders

Autor:innen und Institutionen

  • Interdepartmental Program "Autism 0-90", "G. Martino" University Hospital of Messina, Messina, Italy.
  • IRCCS Centro Neurolesi "Bonino Pulejo", Messina, Italy.
  • Service for Neurodevelopmental Disorders & Laboratory of Molecular Psychiatry and Neurogenetics, University "Campus Bio-Medico", Rome, Italy.
  • Mafalda Luce Center for Pervasive Developmental Disorders, Milan, Italy.
  • Synlab Genetics, Bioggio, Switzerland.
  • Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, Arizona, USA.

ORCID-Profile: Francesca Cucinotta, Carla Lintas, Pasquale Tomaiuolo, Ignazio Stefano Piras, Maria Luisa Scattoni, Antonio M Persico

Förderung

  • Ministero della Salute

Zitieren

APA

Cucinotta, F., Lintas, C., Tomaiuolo, P., Baccarin, M., Picinelli, C., Castronovo, P., Sacco, R., Piras, I. S., Turriziani, L., Ricciardello, A., Scattoni, M. L., & Persico, A. M. (2023). Diagnostic yield and clinical impact of chromosomal microarray analysis in autism spectrum disorder. Molecular Genetics & Genomic Medicine, 11(8). https://doi.org/10.1002/mgg3.2182

Vancouver

Cucinotta F, Lintas C, Tomaiuolo P, Baccarin M, Picinelli C, Castronovo P, et al. Diagnostic yield and clinical impact of chromosomal microarray analysis in autism spectrum disorder. Molecular Genetics & Genomic Medicine. 2023;11(8). doi:10.1002/mgg3.2182

BibTeX
@article{Cucinotta2023,
  author = {Cucinotta, Francesca and Lintas, Carla and Tomaiuolo, Pasquale and Baccarin, Marco and Picinelli, Chiara and Castronovo, Paola and Sacco, Roberto and Piras, Ignazio Stefano and Turriziani, Laura and Ricciardello, Arianna and Scattoni, Maria Luisa and Persico, Antonio M},
  title = {Diagnostic yield and clinical impact of chromosomal microarray analysis in autism spectrum disorder},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2023},
  volume = {11},
  number = {8},
  doi = {10.1002/mgg3.2182}
}
Kostenlos starten →